Major pediatric group makes its own vaccine recs

 

The American Academy of Pediatrics released its own immunization schedule for viruses including influenza, RSV, and Covid-19 this morning. The AAP recommends the covid shot for all children 6 months to almost 2 years of age, as well as older kids who are at higher risk for severe disease. This diverts from the FDA’s vaccine framework, which limits access to Covid vaccines to people 65 and older, plus others who are at high risk of becoming seriously ill if they are infected.

“The AAP will continue to provide recommendations for immunizations that are rooted in science and are in the best interest of the health of infants, children and adolescents,” AAP President Susan J. Kressly said in a statement. It’s unclear what will happen now, as the AAP has been in sync with the CDC’s Advisory Committee on Immunization Practices for decades. Read more from STAT’s Anil Oza on what’s ahead.

Medical devices

A brain implant to translate inner monologue

Brain implant companies like Neuralank have raised hundreds of millions of dollars to give people with paralysis the ability to speak through a computer. A new study shows progress on a related but distinct problem: translating inner speech, or a person’s inner monologue as they think about what to say.

As STAT’s Rose Broderick reports, unlike “attempted speech,” inner speech doesn’t activate the muscles involved in talking, so figuring out how to decode it could have advantages for people with movement disorders such as amyotrophic lateral sclerosis. In a proof-of-concept study, four participants a computer semi-reliably decoded inner speech in real time, achieving up to 74% accuracy, from a 125,000-word vocabulary.

Read more here

from AXIOS:
Abortion pill fight reaches pharmacy CEOs
By Maya Goldman
Illustration of office chairs around a large white round pill on a green background.
Illustration: Sarah Grillo/Axios
A year after the Supreme Court preserved abortion pill access, the fight over dispensing mifepristone is shifting from courtrooms to boardrooms as anti-abortion forces press pharmacy chains not to sell the drugs.

The big picture: Costco last week said it won’t stock mifepristone at its more than 500 pharmacies. Conservative groups are pushing other pharmacies — including Walgreens and CVS, which offer the pills in states where abortion is legal — to follow suit.

  • “We can effectuate real change by talking to these companies and engaging with them,” said Michael Ross, legal counsel for Alliance Defending Freedom’s corporate engagement team. “Hopefully Costco will be a trendsetter.”
  • But those efforts are making retail pharmacies a new ground zero in the fight over abortion access. Costco got swift criticism from one of its home-state senators, Washington Democrat Patty Murray, for accommodating “far-right extremists” she said were whipsawing the availability of basic care.

Between the lines: Pharmacy chains were destined to be involved after the FDA in 2023 allowed retailers to apply for certification to dispense mifepristone, which is part of a two-step protocol used to medically end a pregnancy through 10 weeks.

  • The drug, which FDA first approved in 2000, has traditionally been dispensed at doctors’ offices, hospitals or health clinics. But as states across the country restrict abortion, mifepristone prescribing via telehealth has significantly increased.

State of play: Costco says it won’t pursue approval to dispense mifepristone because demand for the drug is low. The company’s understanding is that patients generally get the drug directly from their medical providers, it said in an email.

But the decision, which reportedly came after more than a year of deliberations, is one anti-abortion groups have been pushing for. It extends beyond Costco’s membership, since nonmembers can fill prescriptions at its drug counters.

Read more

Trump’s war on health numbers
By Erica Pandey
Photo illustration of President Trump stopping the progression of a line chart with his finger
Illustration: Sarah Grillo/Axios. Photo: Brendan Smialowski/AFP via Getty Images
The Trump administration is undermining or has stopped collecting key nonpartisan data that kept the public informed about the state of the nation and its health.

Why it matters: From Congress to city halls to boardrooms, critical decisions rely on accurate government data and public trust in that data. Without it, leaders risk making costly mistakes that could affect millions of people.

Health data of all kinds is evaporating, either as a result of government orders to eliminate diversity, equity and inclusion or due to staffing cuts, the Washington Post reports.

  • The CDC is no longer collecting gender data on any programs, including violence prevention and mental health programs, the Post notes. The agency has also stopped collecting concussion data as well as analyzing data around drownings.
  • The government has stopped federal collection of abortion data, numbers historically used to predict birth rates.
  • The Substance Abuse and Mental Health Services Administration has stopped updating its database on drug use trends, which could make it harder to track street drugs and overdoses.

The bottom line: While some states and private organizations are stepping in to fill gaps left by federal agencies, the loss of government numbers and the erosion of public trust in those numbers could have lasting consequences.

Go deeper

from Endpoint News:

Warren Buffett’s Berkshire Hathaway took a $1.6 billion stake in UnitedHealth Group. The move came as a surprise, given some of Buffett’s past comments on healthcare. With the launch of a joint venture with JP Morgan and Amazon, Buffett had called healthcare costs a “hungry tapeworm” on the economy.

“While UNH shares are optically inexpensive – which we know is an important screen for Berkshire – it is hard to square this investment with Buffett’s historical opinions of the healthcare market,” Deutsche Bank analysts wrote in a note Friday, pointing out that Berkshire has historically invested more in providers, rather than a massive insurance operation like UnitedHealth.

Facebook
Twitter
LinkedIn
Pinterest
Email

Related Posts

What is hyperphosphatemia?

Symptoms Causes Diagnosis Treatment Prevention Outlook Excess phosphate in the blood is known as hyperphosphatemia. The most common cause is kidney disease, but other conditions

Read More »
Scroll to Top